Association of passive smoking with cognitive impairment in older adults is unclear. We carried out a systematic literature review and a new study to determine the association. There were 3 cross-sectional studies published, showing a significant association of passive smoking with cognitive impairment (a relative risk (RR) of about 1.30-1.90). In the new cohort study, we interviewed 1081 never-smoking participants aged ! 65 years in China using a standard method of the Geriatric Mental State-Automated Geriatric Examination for Computer Assisted Taxonomy and found a significant association with dose response; multivariate adjusted RR was 1.02 (95% confidence interval 0.67-1.55) in >0 to 49 exposure level years of passive smoking, 1.57 (1.00-2.47) in 50 to 99, and 2.12 (1.24-3.63) in !100, trend P ¼ .008. The relationship seems not to be a reverse causality of the effect. Passive smoking could be considered an important risk factor for cognitive impairment in older adults. Avoiding exposure to passive smoking would help to preserve cognitive decline in later life.
Introduction
There is evidence that active smoking significantly increases the risk of cognitive impairment and dementia in older adults. [1] [2] [3] As passive smoking has been reported to be a risk factor for many serious health morbidities similar to those associated with active smoking, 4 it is reasonable to assume that a link between passive smoking and cognitive impairment and dementia may also exist. In particular, passive smoking has been shown to be a risk factor for cardiovascular disease and pulmonary function impairment, [5] [6] [7] which in turn are known risk factors for some types of dementia 8 and cognitive impairment. 9 Previous research has shown that even low-level exposure to passive smoking has a negative effect on the cognitive abilities of children and adolescents; 10 however, the effects of passive smoking on cognitive impairment and dementia in later life remain unclear. For example, Orsitto et al 11 did not find an association of passive smoking with dementia. Conversely, Barnes et al 12 reported that high levels of passive smoking increased the risk of dementia when in combination with a history of carotid artery stenosis. It may be that while the link between passive smoking and dementia is uncertain, a stronger association may exist between passive smoking and cognitive impairment; however, this is less explored. The direction of causality between passive smoke exposure and cognitive decline is also unclear; there may be a reverse causality that has not yet been investigated, whereby cognitive decline could increase an individual's exposure to passive smoke due to their inability to reduce or moderate their own exposure. The aim of the present study was to determine the association of passive smoking with cognitive impairment. To do this, we conducted a systematic literature review and described a new study of older adults who were heavily exposed to passive smoking to determine the association of passive smoking with increased risk of cognitive impairment. In the new cohort study, we examined whether there was a dose-response relationship between duration and level of exposure and risk of cognitive impairment, and whether there was evidence of a reverse causality relationship.
Methods

Worldwide Literature Review
We searched Medline, Web of Knowledge, and Excerpta Medica database (date range 1966-2012) to identify studies eligible for inclusion in this study. We used combinations of keywords for passive smoking (tobacco, tobacco smoke, environmental tobacco smoke, passive smoking, and second hand smoke) and cognitive functioning (cognition, cognitive function, cognitive impairment, cognitive decline, Alzheimer's disease, dementia, and executive function and memory). Full texts of all articles, which investigated the association between passive smoking and cognitive functioning were retrieved for further evaluation. We also manually searched the bibliographies of selected articles for additional studies. The literature search was completed in February 2012.
To be eligible for inclusion in this review, a study must have used both a measure of exposure to passive smoking (through questionnaire or biomarkers 13 ) and at least one measure of cognitive functioning in humans. As cognitive impairment is different from dementia in terms of pathology and prognosis, we have only included studies of cognitive impairment as an outcome measure. Studies were excluded if they did not clearly define both of these variables, or if passive smoking was not considered independently of other variables such as other urban pollutants. Cognitive measures were required to be objective through the use of recognized, validated tools and to measure cognitive functioning or impairment in late life. In this review, we include only those studies involving older adults aged !60 years. Studies including both cognitive impairment and dementia as outcome measures were considered for review if these had been reported independently in relation to passive smoking. They would cover patients with different levels of cognitive impairment.
We included all eligible studies published between 1966 and 2012, and information was extracted from eligible articles based on predefined criteria. The schematic presentation of identifying articles for review is shown in Figure 1 . Three studies were identified which had investigated cognitive impairment in older adults in relation to passive smoking. 11, 14, 15 We extracted information on the study publication year, country, the study design, sampling of participants, the number of participants, participant age and gender, the percentage of participants exposed to passive smoking, the measurement of passive smoking used, the measurement of cognitive functioning, the covariates included in the analyses, variables adjusted for within the analysis, and the outcome of the study. Details of studies are shown in Table 1 .
The Anhui Cohort Study in China
The population of this study was derived from the third wave survey of the Anhui cohort study in China. 16 The methods of the Anhui cohort study have been fully described before. 17, 18 In brief, in 2001 to 2003, we examined a random sample of 3336 residents aged !60 years in Anhui province (wave 1) using the standard interview method of the Geriatric Mental State (GMS) questionnaire-a comprehensive semistructured mental state interview. 19 The main interview materials were a general health and risk factors record and the GMS questionnaire. 17, 18 According to the standard procedures of the Scottish monitoring trends and determinants in cardiovascular disease (MONICA) study, 20 we measured systolic and diastolic blood pressure, height, weight, and waist circumference for all the participants. We reexamined 2608 cohort members (wave 2) after 1 year of baseline investigation.
During the period of 2007 to 2009, we successfully examined 1757 participants for wave 3 of the survey within the cohort (all aged ! 65 years), with a response rate of 82.4% of surviving cohort members. 16 In the interview, we added a detailed questionnaire of active smoking and passive smoking exposure derived from the Scottish MONICA study into the risk factors record. 6 The current smokers were those who gave a positive answer to ''Do you smoke cigarettes now'', with additional information including the number of cigarettes smoked daily, the maximum number smoked daily in the last 2 years, and the duration of their smoking habit. If not currently smoking, participants were asked about their smoking history and related information. We defined ''never smokers'' as those who gave negative answers to both the enquiries. After giving the details of smoking status, all participants were asked ''Have you experienced passive smoking?'' with answer of Yes or No, and 3 sources of passive smoking were given (home, workplace, and other places) with respondents to 3 choices, no, none at all; yes, some; or yes, a lot. We also asked how many years they had been exposed to each of 3 sources of passive smoking. Ethical approval for the study was obtained from the Research Ethics Committee (REC), University College London, UK, and the REC of the Anhui Medical University and the local governments in China.
We employed a computer program-assisted diagnosis, the Automated Geriatric Examination for Computer Assisted Taxonomy (AGECAT), to analyze the information from the GMS to determine the cognitive levels and other principal mental disorders in the study for each participant. 17, 18 The methods of this algorithm have been fully described before. 17, 18 Briefly, AGE-CAT analyses of the GMS data bring symptom components together into groups that typify the major symptom areas of each diagnostic syndrome (organic disorder, depression, mania, schizophrenia and paranoia, obsessional, phobic, hypochondriacal, and general anxiety). Individual participants were allocated to the levels of confidence of diagnosis (0-5) on each of the 8 diagnostic syndromes. Then, the various syndrome levels were compared with one another to derive a final differential diagnosis, a level of confidence of diagnosis from 0 to 5. A level of !3, in most circumstances, designates a ''case level'' that corresponds to a level of severity that warrants clinical intervention. In this older Chinese population, we took organic levels !3 as cognitive impairment for analysis as we did previously. 15 
Data analysis
For the literature review, we evaluated all previously published studies according to the standard methods which we used before. 21 Due to the small number of studies and variations in their outcome measurements (Table 1) , we were not able to run a meta-analysis. In the Anhui study, we analyzed data restricted to participants who were lifelong never smokers (n ¼ 1081). Using a multivariate regression model as we did previously, 22 we calculated a relative risk (RR) of cognitive impairment among participants who were exposed to passive smoking. In the model, we adjusted for potential confounding factors, including sociodemography, social network, head injury, cardiovascular disease other risk factors, respiratory disease, 15 consumption of vegetables and fish. 23 To investigate the possibility of whether the onset of cognitive impairment made older adults more prone to exposure to passive smoking (reverse causality), we examined the association of baseline cognitive impairment at wave 1 with follow-up exposure to passive smoking at wave 3. We also carried out a sensitivity analysis for the association of passive smoking exposure with cognitive impairment at wave 3 after excluding patients with baseline cognitive impairment. All analyses were performed in Stata, version 11 (StataCorp, LP, College Station, Texas).
Results
Worldwide Literature review Table 1 shows characteristics of the 3 studies identified for inclusion in the review. All were cross-sectional studies and were published during the last 4 years. One used biomarkers to measure passive smoking, 14 while the other 2 used a questionnaire.
In a UK adult population aged !50 years (mean age 65.1 years), Llewellyn et al 14 found that nonsmoking (including never-smoking and ex-smoking) men and women who had high levels of salivary cotinine (fourth quartile vs first quartile) had a 44% increased risk of performing within the lowest 10% of the sampled population on a number of neuropsychological tests (attention, orientation, memory, numeracy, word, and generation) in which cognitive function was carefully and comprehensively measured for each participant, and the lowest 10% of the sampled population could be taken as equivalent to cognitive impairment, even after adjustment for 13 confounding variables. There was a dose-response relationship between cotinine level and risk of cognitive impairment. A separate data analysis for smoking status demonstrated a 70% increased risk of cognitive impairment for never smokers exposed to high levels of passive smoking, and a 32% increase risk for former smokers.
As part of the 4-Province Study in China, 1979 neversmoking women aged !60 were identified. 15 All participants were interviewed using the standard method of the GMS-AGE-CAT 17 and the 10/66 dementia diagnosis algorithm. 24 The details of passive smoking exposure were measured using the questionnaire derived from the Scottish MONICA study 6 and cognitive impairment by the GMS-AGECAT diagnosis. 15 Women exposed to passive smoking had a 39% increased risk of cognitive impairment. The association was dose dependently related to the intensity and the duration of exposure to passive smoking.
Orsitto et al 11 examined data of 933 patients aged !65 years who were consecutively admitted to a geriatric hospital unit in Italy. Passive smoking was assessed through a questionnaire and defined as having had exposure to passive smoking for at least 1 hour per week. Participants completed a series of neuropsychological tests and assessments to determine the level of cognitive impairment. According to Petersen criteria, 98 patients were diagnosed as having mild cognitive impairment (MCI), and 124 patients were diagnosed as having dementia. The authors found that the prevalent rates of passive smoking in patients with MCI and dementia were 24% and 12%, which is significantly higher than that in patients with normal cognitive function (8%). Age and education level adjusted odds ratio (OR) for passive smoking in MCI versus normal cognitive function was 1.9 (95% confidence interval [CI] 1.0-3.5) but not increased for patients with dementia (Table 1 ). However, in the analysis, it was unclear whether active smokers (maybe also including passive smoking) were excluded. They did not present the results of MCI and dementia combined as a total of cognitive impairment. Based on their crude data, we computed an unadjusted OR of 2.91 (1.09-4.53) for all cognitive impairment after excluding active smoking participants. However, this OR is likely to be reduced after adjustment for age, educational levels, and other confounding variables. The study did not examine a dose-response relationship.
The Anhui cohort study
Among 1081 never-smoking participants, 350 (32.4%) were exposed to passive smoking. Compared with those not exposed to passive smoking, they were more likely to be younger, women, living in a rural area, have lower education, be married, have a religious belief, and eat less fish and fewer vegetables ( Table 2 ). There were no significant differences in other factors listed in Table 2 , including cardiovascular disease (indicated by hypertension and angina) between exposed and nonexposed groups.
We documented 166 (15.4%) cognitive impairment cases. Table 3 shows the numbers and RR of cognitive impairment cases in relation to level and duration of exposure to passive smoking. After adjustment for age, sex, body mass index, urban-rurality, educational level, occupational class, marital status, religious belief, chronic obstructive pulmonary disease , head injury, hypertension, diabetes, stroke, and consumptions of fish and fresh vegetables, we still found that the heaviest exposure in terms of passive smoking level and duration was significantly associated with cognitive impairment. There was a significant cumulative dose relationship, trend P ¼ .008 (Table 3) .
Among these 1081 never-smoking participants, we identified that 80 had cognitive impairment at wave 1 and 1001 did not and found that there were no significant differences in passive smoking exposure measured at wave 3 between 2 groups (27.5% vs 32.8%, P ¼ 0.333). Data analysis after excluding the 80 patients showed no substantial changes; for example, compared to nonexposure, the multivariate adjusted RR was 0.81 (0.50-1.29) in a little exposure to passive smoking and 2.05 (1.39-3.02) in a lot exposure. These further may suggest little reverse causality relationship between passive smoking and cognitive impairment.
Discussion
The association of passive smoking and cognitive impairment in older adults has been examined in a systematic literature review and followed by a new cohort study in China. The overall findings showed that the risk of cognitive impairment appeared to increase with passive smoking exposure by between 30% and 90%. The Anhui cohort study further showed a cumulative dose-dependent association of passive smoking with cognitive impairment is consistent with the literature regarding the relationship between passive smoking and coronary heart disease. 5 This association was independent of socioeconomic, lifestyle, and other possible risk factors for cognitive impairment. The new cohort study may also help rule out the possibility that the onset of cognitive impairment made older people more prone to passive smoking, as no significant differences in passive smoke exposure over the course of the study were observed between those with and without cognitive impairment at wave 1. This may help determine a possible casual relationship between passive smoking and risk of cognitive impairment. There is therefore growing evidence that passive smoking is harmful to cognitive health in older adults.
It is not surprising for us to observe the association of passive smoking with cognitive impairment in Chinese older adults. China is the world's largest producer and consumer of tobacco, with Chinese nonsmokers experiencing high levels of exposure to passive smoke throughout their lives. Both earlier and more recent surveys 25, 26 in China have shown that the prevalence rate for passive smoking among nonsmokers remains around 53.5%. Tobacco smoke contains many toxic chemicals, including lead, which are harmful to the brain. 27 Nicotine acts on the cholinergic system, 28, 29 and long-term exposure may lead to the overstimulation of neurons implicated in learning and memory. 28 Furthermore, increased concentrations of carbon monoxide in the blood can impair oxygen flow around the brain. 30 Previous studies reported that other air pollutants could also be associated with increased risk of cognitive impairment in older adults. Power et al 31 found that trafficrelated air pollution was associated with increased risk of having a low Mini-Mental State Examination score ( 25) in 680 US men aged 71 years (OR 1.3, 95% CI 1.1-1.6). 31 A similar relationship between traffic-related air pollution and cognitive decline was seen in older women aged 68 to 79 years residing in Germany, where distance from home to the nearest main road was dose dependently associated with risk of MCI. 32 Tobacco smoke and other types of pollution contain lead, which also increases the risk of cognitive decline. 27 Our findings in this study could have implications for the prevention of age-related cognitive impairment and dementia, as the observed deleterious effects of passive smoking on cognition suggest neurotoxicity caused by exposure. Some investigators considered that the effect
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Journal of Geriatric Psychiatry and Neurology 26(4) of passive smoking on cognitive impairment may be due to indirect causal pathways such as cardiovascular disease, 12 while other studies showed passive smoking as a risk factor for cardiovascular disease. 5, 6 In the data analysis for the Anhui cohort, we adjusted for cardiovascular disease and risk factors and still found a significant association of passive smoking with cognitive impairment. We therefore argue that poor performance in some of the cognitive outcome measures in the studies described in the literature review have implications for the link between passive smoking and dementia, as those with MCI are at an increased risk of subsequently developing dementia. Although the Anhui third wave survey data were crosssectional, our study on passive smoking status should not have been affected by differential reporting bias in health conditions. Most Chinese people are unaware of the health hazards of either active or passive smoking, with only 32% knowing that passive smoking poses serious health hazards and 21% understanding that smoking can cause cardiovascular diseases. 33 It was further supported by our data that have not shown any significant differences in cardiovascular disease and diabetes between passive smoking and nonpassive smoking groups ( Table 2) . Even fewer people have considered that passive smoking is related to cognitive impairment and dementia.
Thus, bias resulting from overreporting of exposure in patients with cognitive impairment and their carers was unlikely. The Anhui cohort data may help rule out a reverse causality relationship between passive smoking and cognitive impairment. Although there were no significant differences in passive smoking exposure measured at wave 3 between participants with and without baseline cognitive impairment at wave 1, we do not know longer term exposures that may have existed during or prior to wave 1. But compared to younger population, older people would be less likely to get passive smoking exposure in next 5 years (from wave 1 to wave 3), and the possibility of passive smoking following cognitive impairment after the start of the study is small. After excluding those participants with baseline cognitive impairment at wave 1, the associations of passive smoking with cognitive impairment at wave 3 remained significant, further suggesting little evidence of the reverse causality relationship. In the data analysis, we adjusted for 15 important variables and still found the cumulative doseresponse relationship between passive smoking exposure and risk of cognitive impairment. However, we did not have variables of cardiovascular exercise and apolipoprotein E genotype for adjustment. Based on the magnitudes of the RRs and 95% CIs shown in Table 3 , we do not think that further analysis for these factors and 
206
Journal of Geriatric Psychiatry and Neurology 26 (4) other unmeasured factors would substantially change our findings of the association of passive smoking with cognitive impairment in older adults. In the Anhui study, we did not measure the cotinine levels to quantify exposure to passive smoking, which is a limitation. Self-report measures of passive smoking may underestimate exposure, 34 although it has been demonstrated to consistently distinguish between the relative levels of passive smoking. 35 Thus, the findings of the association in the Anhui study may be more conservative. However, in our systematic literature review, one study that used cotinine as a biomarker for passive smoking demonstrated such a significant association with cognitive performance. 14 The findings of the current study are therefore robust.
Conclusion
This study provides evidence that passive smoking is associated with global cognitive deficits in older adults and could be a risk factor for cognitive impairment. At present, 93% of the world's population still lives in countries that are not fully covered by smoke-free public health regulations. 4 Public policy should continue to actively focus on reducing exposure in public in an attempt to limit the health costs associated with cognitive impairment and dementia. Further campaigns aimed at discouraging cigarette smoking and avoiding passive smoking exposure could contribute to preserving cognitive function and the prevention of dementia worldwide. Abbreviations: RR, relative risk; CI, confidence interval; BMI, body mass index; COPD, chronic obstructive pulmonary disease. a Adjusted for age, sex, BMI, urban-rurality, educational level, occupational class, marital status, religion, head injury, hypertension, diabetes, stroke, COPD, and consumptions of fish and fresh vegetables. b Answers to the questions of passive smoking exposure at home, at work, and in other places, with ''no, none at all,'' ''yes, some,'' and ''yes, a lot'' were given score of 0, 1, and 2, respectively. For the total exposure from 3 passive smoking sources, every participant should have an added-in total score. For example, if he or she was exposed to passive smoking ''yes, a lot'' at home, ''no, none at all'' at work, and ''yes, some'' in other places, we would mark his or her to have 3 scores (from 2 þ 0 þ 1). c Duration (year) was added from 3 exposure sources. d It is the production of exposure level multiplied by exposure duration (years) for each source of passive smoking, and then added up for the total. For example, if he or she was exposed to passive smoking ''yes, some'' at home for 20 years, ''yes, a lot'' at work for 15 years, and ''yes, some'' in other places for 10 years, we would mark his or her to have a total level-duration exposure for 60 level-years (1 Â 20 þ 2 Â 15 þ 1 Â 10).
